Literature DB >> 8124659

Phantom limb pain. Mechanism-based management.

R A Sherman1.   

Abstract

Clinically significant phantom limb pain occurs among a large minority of amputees. Most suffer at least occasional episodes. It is becoming increasingly apparent that although psychological factors are not important in the cause of phantom pain, a variety of physiologic problems related to the residual limb are critical to it. Referred pain, initiated by decreased blood flow and microspasms in the residual limb along with problems caused by prosthetics account for most of the phantom pain problems seen clinically. Some pain is referred to the phantom pain from other sites in the body such as the back. Treatments for phantom pain that are not based on recently elucidated physiologic mechanisms have proven to be ineffective for the vast majority and cannot be applied indiscriminantly with any hope of consistent success. Mechanism-based treatments related to specific symptoms can be effective when used appropriately. They include the use of peripheral vasodilators, muscle relaxants, and biofeedback to correct specific problems with blood flow and muscle tension in the residual limb.

Entities:  

Mesh:

Year:  1994        PMID: 8124659

Source DB:  PubMed          Journal:  Clin Podiatr Med Surg        ISSN: 0891-8422            Impact factor:   1.231


  7 in total

Review 1.  Optimal treatment of phantom limb pain in the elderly.

Authors:  R Baron; G Wasner; V Lindner
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

2.  A randomized controlled study to evaluate the efficacy of noninvasive limb cover for chronic phantom limb pain among veteran amputees.

Authors:  An-Fu Hsiao; Robyn York; Ian Hsiao; Ed Hansen; Ron D Hays; John Ives; Ian D Coulter
Journal:  Arch Phys Med Rehabil       Date:  2012-04       Impact factor: 3.966

Review 3.  Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults.

Authors:  Mark I Johnson; Matthew R Mulvey; Anne-Marie Bagnall
Journal:  Cochrane Database Syst Rev       Date:  2015-08-18

4.  Treating intractable phantom limb pain with ambulatory continuous peripheral nerve blocks: a pilot study.

Authors:  Brian M Ilfeld; Tobias Moeller-Bertram; Steven R Hanling; Kyle Tokarz; Edward R Mariano; Vanessa J Loland; Sarah J Madison; Eliza J Ferguson; Anya C Morgan; Mark S Wallace
Journal:  Pain Med       Date:  2013-03-14       Impact factor: 3.750

5.  A sleeping phantom leg awakened following hemicolectomy, thrombosis, and chemotherapy: a case report.

Authors:  Melita J Giummarra; John L Bradshaw; Michael Er Nicholls; Nellie Georgiou-Karistianis; Stephen J Gibson
Journal:  J Med Case Rep       Date:  2011-05-25

Review 6.  Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.

Authors:  Domenico Intiso; Mario Basciani; Andrea Santamato; Marta Intiso; Filomena Di Rienzo
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

Review 7.  Recent advances in understanding and managing phantom limb pain.

Authors:  Andrea Aternali; Joel Katz
Journal:  F1000Res       Date:  2019-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.